Dermatology patients on biologics and certain other systemic therapies should receive a “booster” messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations

Detalles Bibliográficos
Autores principales: Waldman, Reid Alexander, Grant-Kels, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021
Materias:
A Clinician's Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381623/
https://www.ncbi.nlm.nih.gov/pubmed/34437985
http://dx.doi.org/10.1016/j.jaad.2021.08.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381623/
https://www.ncbi.nlm.nih.gov/pubmed/34437985
http://dx.doi.org/10.1016/j.jaad.2021.08.031

Ejemplares similares